Delivery Order SPE2DB22D2006-SPE2DB24FV8JS
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,175.24 to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract is for the supply of 1,200,000 units of Bicillin L-A 2 mL, a pharmaceutical product, with a period of performance through March 29, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,906,442 units of Bicillin L-A 2,400,000 unit, 4 ml vials. The award, with a ceiling value of $3,856.01, has an ultimate completion date of March 11, 2024. This delivery order is part of a larger, single award indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, in 2 milliliter vials. The $1,175.24 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a potential value of $1,175.24. The delivery order has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract, valued at $3,525.75, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,951.20, is for the delivery of 1,200,000 units of the medication Bicillin L-A. The contract has an ultimate completion date of May 30, 2025 and was awarded on May 29, 2025. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,540.69 contract is for the delivery of 4,564,115,056 units of Bicillin L-A 2,400,000 unit, 4ML vials. This delivery order falls under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of 2ML Bicillin L-A, a pharmaceutical product, with a potential value of $1,175.24. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,431.88 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,491,990 units of Bicillin L-A 2,400,000 units 4ML pharmaceutical product. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure essential medical...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV8JSDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2 milliliter vials. The total potential value of the contract is $76,391.25 and the period of performance extends through February 27, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a maximum potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $76.4k | 2/26/24 |